Scholars Central

Conference abstractPublished 12 Nov 2012

Visa-BikDD and visa-miRNA nanoparticles targeting to breast cancer and breast cancer stem cells

Authors: Xiaoming Xie

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

D evelopment of cancer gene therapy has been hampered by the fact that there are no effective cancer-specific expression vectors available, which is critical for improving therapeutic efficacy and reducing toxicity in clinics. To overcome this problem, we recently developed a safe and effective strategy for targeting a potent pro-apoptotic gene (BikDD) to the pancreatic tumors (Xie et al. Cancer Cell, 2007). A VISA system (VP16-Gal4-WPRE integrated systemic amplifier) was engineered by using the two-step transcriptional amplification (TSTA) system and the posttranscriptional regulatory element of the woodchuck hepatitis virus (WPRE). The VISA system can boost the activity of cancer-specific promoters by an average of 600 folds compared to their basal levels. C-VISA (CCKAR-VISA) nanoparticles transcriptionally which targets transgene expression effectively to pancreatic tumors in vivo is moving into clinical trials at University of Texas M.D. Anderson Cancer Center, USA. In the current study, we identified hTERT, ß-cateinin, claudin-4, and FASN, CD44, ALDH1 promoters as breast cancer-and breast cancer stem cell-selective promoters, and amplified their activity to hundreds of folds greater by the ?VISA? system without loss of their specificity. We further demonstrated significant antitumor activity of targeted BikDD (a mutant Bik) or an antioncogenic miRNA expression driven by nanoparticles of the hTERT-VISA-BikDD vectors or hTERT-VISA-miRNA vectors in breast cancer and breast cancer stem cells in multiple breast cancer models of living imaging by the Xenogen IVIS imaging system with limited toxicity. Thus, our newly developed hTERT-VISA-BikDD and hTERT-VISA-miRNA vectors nanoparticles are an innovative strategy for potentially eradicating breast cancer

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Cell Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cell Science & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “Xiaoming Xie”